You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • S100 Cumulative distribution of patients by change in FVC% predicted in the inpulsis® trials of NINTEDANIB in patients with idiopathic pulmonary fibrosis

Article metrics

Article menu
Download PDFPDF
Idiopathic Pulmonary Fibrosis Therapy
S100 Cumulative distribution of patients by change in FVC% predicted in the inpulsis® trials of NINTEDANIB in patients with idiopathic pulmonary fibrosis

 

Online download statistics by month:

Online download statistics by month: November 2016 to September 2024

AbstractFullPdf
Nov 20162309
Dec 20161602
Jan 20173004
Feb 20171101
Mar 2017701
Apr 20171304
May 20172203
Jun 20171801
Jul 20171600
Aug 20171600
Sep 20172200
Oct 20171400
Nov 2017600
Dec 20171800
Jan 20182401
Feb 20185600
Mar 20181602
Apr 20183401
May 20181600
Jun 20182200
Jul 20182003
Aug 20181500
Sep 2018600
Oct 20183800
Nov 2018800
Dec 20181200
Jan 2019400
Feb 2019600
Mar 20191000
Apr 2019400
May 20191800
Jun 20191401
Jul 2019600
Aug 20191201
Sep 2019152400
Oct 2019600
Nov 20192806
Dec 2019404
Jan 20201003
Feb 202015203
Mar 202024404
Apr 2020605
May 20201409
Jun 20201203
Jul 20201602
Aug 2020804
Sep 20202203
Oct 2020802
Nov 20201203
Dec 2020602
Jan 2021406
Feb 2021003
Mar 2021602
Apr 2021605
May 2021203
Jun 2021003
Jul 2021006
Aug 2021004
Sep 2021003
Oct 202110021
Nov 20212011
Dec 20211201
Jan 2022001
Feb 2022600
Mar 2022601
Apr 2022401
May 2022808
Jun 2022402
Jul 2022401
Aug 2022801
Sep 2022404
Oct 2022405
Nov 2022206
Dec 20221000
Jan 2023603
Feb 2023400
Mar 2023601
Apr 2023201
May 2023004
Jun 2023200
Jul 2023402
Aug 2023400
Sep 2023801
Oct 2023602
Nov 2023604
Dec 20232204
Jan 20241000
Feb 2024400
Mar 2024202
Apr 20241601
May 2024600
Jun 20241200
Jul 20241801
Aug 2024600
Sep 20241801
Total29090212